Literature DB >> 11468466

Sutureless liver repair and hemorrhage control using laser-mediated fusion of human albumin as a solder.

Y Wadia1, H Xie, M Kajitani.   

Abstract

BACKGROUND: Major liver trauma has a high mortality because of immediate exsanguination and a delayed morbidity from septicemia, peritonitis, biliary fistulae, and delayed secondary hemorrhage. We evaluated laser soldering using liquid albumin for welding liver injuries.
METHODS: Fourteen lacerations (6 x 2 cm) and 13 nonanatomic resection injuries (raw surface, 8 x 2 cm) were repaired. An 805-nm laser was used to weld 53% liquid albumin-indocyanine green solder to the liver surface, reinforcing it by welding a free autologous omental scaffold. The animals were heparinized and hepatic inflow occlusion was used for vascular control. For both laceration and resection injuries, 16 soldering repairs were evaluated acutely at 3 hours. Eleven animals were evaluated chronically, two at 2 weeks and nine at 4 weeks.
RESULTS: All 27 laser mediated-liver repairs had minimal blood loss compared with the suture controls. No dehiscence, hemorrhage, or bile leakage was seen in any of the laser repairs after 3 hours. All 11 chronic repairs healed without complication.
CONCLUSION: This modality effectively seals the liver surface, joins lacerations with minimal thermal injury, and works independently of the patient's coagulation status.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11468466     DOI: 10.1097/00005373-200107000-00008

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  2 in total

1.  Hemostasis of the liver, spleen, and bone achieved by electrocautery greased with lidocaine gel.

Authors:  Andy Petroianu
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

2.  Laparoscopic nonanatomic hepatic resection employing the LigaSure device.

Authors:  Douglas L Constant; Douglas P Slakey; Richard J Campeau; J Bruce Dunne
Journal:  JSLS       Date:  2005 Jan-Mar       Impact factor: 2.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.